- Home
- TTGT vs LXRX Comparison
TTGT vs LXRX Comparison
Compare TTGT & LXRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TTGT
- LXRX
- Stock Information
- Founded
- TTGT 1999
- LXRX 1995
- Country
- TTGT United States
- LXRX United States
- Employees
- TTGT N/A
- LXRX 103
- Industry
- TTGT Telecommunications Equipment
- LXRX Biotechnology: Pharmaceutical Preparations
- Sector
- TTGT Telecommunications
- LXRX Health Care
- Exchange
- TTGT Nasdaq
- LXRX Nasdaq
- Market Cap
- TTGT 468.3M
- LXRX 552.4M
- IPO Year
- TTGT 2007
- LXRX 2000
- Fundamental
- Price
- TTGT $5.85
- LXRX $1.49
- Analyst Decision
- TTGT Strong Buy
- LXRX Buy
- Analyst Count
- TTGT 5
- LXRX 5
- Target Price
- TTGT $16.40
- LXRX $3.23
- AVG Volume (30 Days)
- TTGT 542.9K
- LXRX 3.0M
- Earning Date
- TTGT 11-10-2025
- LXRX 11-11-2025
- Dividend Yield
- TTGT N/A
- LXRX N/A
- EPS Growth
- TTGT N/A
- LXRX N/A
- EPS
- TTGT N/A
- LXRX N/A
- Revenue
- TTGT $387,100,000.00
- LXRX $58,432,000.00
- Revenue This Year
- TTGT N/A
- LXRX $66.55
- Revenue Next Year
- TTGT $98.75
- LXRX N/A
- P/E Ratio
- TTGT N/A
- LXRX N/A
- Revenue Growth
- TTGT 50.73
- LXRX 1504.83
- 52 Week Low
- TTGT $5.32
- LXRX $0.28
- 52 Week High
- TTGT $33.08
- LXRX $2.18
- Technical
- Relative Strength Index (RSI)
- TTGT 50.31
- LXRX 56.37
- Support Level
- TTGT $5.32
- LXRX $1.39
- Resistance Level
- TTGT $5.75
- LXRX $1.58
- Average True Range (ATR)
- TTGT 0.32
- LXRX 0.11
- MACD
- TTGT 0.00
- LXRX -0.01
- Stochastic Oscillator
- TTGT 63.01
- LXRX 44.26
About TTGT TechTarget Inc.
TechTarget Inc is engaged in the business-to-business (B2B) accelerator, informing and influencing technology buyers and sellers. Through its B2B first-party data and an end-to-end portfolio of data-driven solutions, it services the full B2B product lifecycle for customers from, messaging, and content development to in-market activation via brand, demand generation, purchase intent data, and sales enablement from R&D to ROI.
About LXRX Lexicon Pharmaceuticals Inc.
Lexicon Pharmaceuticals Inc is a biopharmaceutical company. It is engaged in the discovery, development, and commercialization of pharmaceutical products for the treatment of human diseases. Some of its drug candidates are LX9211, an orally-delivered small molecule drug candidate, also developing LX9851, an orally-delivered small molecule drug candidate, as a treatment for obesity and associated cardiometabolic.